Pfizer, BioNTech seek FDA EUA status for Covid-19 vaccine

This article was originally published here

The companies have submitted a request to the FDA to secure FDA EUA status for BNT162b2 mRNA vaccine candidate against SARS-CoV-2. The Covid-19 vaccine is expected to be

The post Pfizer, BioNTech seek FDA EUA status for Covid-19 vaccine appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply